Invesco Dynamic Biotechnology & Genome ETF – AMEX:PBE

Add to watchlist

$67.68

+0.35

+0.52%

Market open

Closed in 2 minutes

-1.33%

month

-1.33%

quarter

+0.93%

year

Market Cap	303.71M
Enterprise value	N/A

P/E	N/A
EV/Sales	N/A
EV/EBITDA	N/A
Price/Sales	N/A
Price/Book	N/A
PEG ratio	N/A
EPS	8.33

Revenue	485.40K
EBITDA	56.62M
Income	56.33M
Revenue Q/Q	N/A
Revenue Y/Y	N/A

Profit margin	0%
Oper. margin	0%
Gross margin	0%
EBIT margin	0%
EBITDA margin	11666.26%

Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.

Invesco Dynamic Biotechnology & Genome ETF (AMEX:PBE): Profit margin
Oct 2013	171.36K	19.98M	11662.06%

Invesco Dynamic Biotechnology & Genome ETF (AMEX:PBE): Debt to assets
Jul 2013	261704564	211.82K	0.08%
Oct 2013	261704564	211.82K	0.08%

Invesco Dynamic Biotechnology & Genome ETF (AMEX:PBE): Cash Flow
Jul 2013	0	0	0
Oct 2013	0	0	0

Invesco Dynamic Biotechnology & Genome ETF
Latest News

Wednesday, 20 November 2024
07:21	Should You Invest in the Invesco Biotechnology & Genome ETF (PBE)?	zacks.com
Monday, 11 November 2024
07:20	Is Invesco Biotechnology & Genome ETF (PBE) a Strong ETF Right Now?	zacks.com
Wednesday, 18 September 2024
07:21	Should You Invest in the Invesco Biotechnology & Genome ETF (PBE)?	zacks.com
Wednesday, 11 September 2024
07:20	Is Invesco Biotechnology & Genome ETF (PBE) a Strong ETF Right Now?	zacks.com
Tuesday, 16 July 2024
07:20	Should You Invest in the Invesco Biotechnology & Genome ETF (PBE)?	zacks.com
Friday, 12 July 2024
07:21	Is Invesco Biotechnology & Genome ETF (PBE) a Strong ETF Right Now?	zacks.com
Monday, 13 May 2024
07:20	Should You Invest in the Invesco Biotechnology & Genome ETF (PBE)?	Zacks Investment Research
Friday, 10 May 2024
07:21	Is Invesco Biotechnology & Genome ETF (PBE) a Strong ETF Right Now?	Zacks Investment Research
Monday, 1 April 2024
10:30	PBE: Biotech Could Be Next Big Winner	Seeking Alpha
Wednesday, 13 March 2024
07:21	Should You Invest in the Invesco Biotechnology & Genome ETF (PBE)?	Zacks Investment Research
Tuesday, 5 March 2024
07:21	Is Invesco Biotechnology & Genome ETF (PBE) a Strong ETF Right Now?	Zacks Investment Research
Monday, 19 February 2024
16:08	3 Biotech Stocks to Buy That Have CRISPR-Like Breakthrough Potential	InvestorPlace
Wednesday, 14 February 2024
17:51	Where Are Biotech ETFs Headed After Q4 Earnings?	Zacks Investment Research
Monday, 12 February 2024
17:21	The Best Time to Invest	InvestorPlace
Tuesday, 16 January 2024
11:28	An ETF Nerd's Exchange Conference Preview	ETF Trends
Tuesday, 9 January 2024
18:03	Should You Invest in the Invesco Biotechnology & Genome ETF (PBE)?	Zacks Investment Research
Wednesday, 3 January 2024
07:31	Is Invesco Biotechnology & Genome ETF (PBE) a Strong ETF Right Now?	Zacks Investment Research
Wednesday, 8 November 2023
07:31	Should You Invest in the Invesco Biotechnology & Genome ETF (PBE)?	Zacks Investment Research
Tuesday, 31 October 2023
07:31	Is Invesco Biotechnology & Genome ETF (PBE) a Strong ETF Right Now?	Zacks Investment Research
Wednesday, 6 September 2023
07:31	Should You Invest in the Invesco Biotechnology & Genome (PBE)?	Zacks Investment Research
Friday, 1 September 2023
19:33	This Week in ETFs: Invesco Makes Changes to 35 Funds	ETF Trends
Thursday, 17 August 2023
08:01	Is Invesco Dynamic Biotechnology & Genome ETF (PBE) a Strong ETF Right Now?	Zacks Investment Research
Monday, 3 July 2023
07:42	Should You Invest in the Invesco Dynamic Biotechnology & Genome ETF (PBE)?	Zacks Investment Research
Monday, 19 June 2023
05:16	PBE: Healthcare Dashboard For June	Seeking Alpha
Wednesday, 7 June 2023
07:33	Is Invesco Dynamic Biotechnology & Genome ETF (PBE) a Strong ETF Right Now?	Zacks Investment Research
Friday, 19 May 2023
14:41	PBE Offers Exposure to Surging Catalent Stock	ETF Trends
Wednesday, 3 May 2023
07:39	Should You Invest in the Invesco Dynamic Biotechnology & Genome ETF (PBE)?	Zacks Investment Research
Friday, 7 April 2023
07:40	Is Invesco Dynamic Biotechnology & Genome ETF (PBE) a Strong ETF Right Now?	Zacks Investment Research
Thursday, 16 March 2023
06:31	PBE: Healthcare Dashboard For March	Seeking Alpha
Monday, 27 February 2023
07:32	Should You Invest in the Invesco Dynamic Biotechnology & Genome ETF (PBE)?	Zacks Investment Research

Ideas & Opinions

Seeking Alpha 14 Jan 2024

Week In Review: China Biopharmas Book $9B In Deals During JP Morgan Conference Week
Seeking Alpha 12 Jan 2024

Horiba: Wonderful Japanese Company At A Very Attractive Price
Seeking Alpha 7 Jan 2024

Week In Review: 2024 Kicks Off With 3 Deals Worth A Total Of $4B
Seeking Alpha 23 Jul 2023

Week In Review: Novartis In $1 Billion Deal For DTx Pharma
Seeking Alpha 24 Aug 2022

CytoDyn: It Only Takes One Hit
Seeking Alpha 24 Aug 2022

Coherus: 2022 Is In Many Ways A Make Or Break Year
Seeking Alpha 23 Aug 2022

Can Intellia One-Up Alnylam In Transthyretin Amyloidosis?
Seeking Alpha 15 Aug 2022

Selecta: ImmTOR Could Change Autoimmune Disorder Treatment Landscape
Seeking Alpha 10 Aug 2022

Sarepta: Advancement In DMD Space With SRP-9001 And Licensed MyoAAV
Seeking Alpha 10 Aug 2022

Catalent: No Catalyst Just Yet

Frequently Asked Questions (FAQ)

What's the price of Invesco Dynamic Biotechnology & Genome ETF stock today?

One share of Invesco Dynamic Biotechnology & Genome ETF stock can currently be purchased for approximately $67.68.
When is Invesco Dynamic Biotechnology & Genome ETF's next earnings date?

Unfortunately, Invesco Dynamic Biotechnology & Genome ETF's (PBE) next earnings date is currently unknown.
Does Invesco Dynamic Biotechnology & Genome ETF pay dividends?

No, Invesco Dynamic Biotechnology & Genome ETF does not pay dividends.
How much money does Invesco Dynamic Biotechnology & Genome ETF make?

Invesco Dynamic Biotechnology & Genome ETF has a market capitalization of 303.71M.
What is Invesco Dynamic Biotechnology & Genome ETF's stock symbol?

Invesco Dynamic Biotechnology & Genome ETF is traded on the AMEX under the ticker symbol "PBE".
What is Invesco Dynamic Biotechnology & Genome ETF's primary industry?

Company operates in the Financial Services sector and Asset Management industry.
How do i buy shares of Invesco Dynamic Biotechnology & Genome ETF?

Shares of Invesco Dynamic Biotechnology & Genome ETF can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
When Invesco Dynamic Biotechnology & Genome ETF went public?

Invesco Dynamic Biotechnology & Genome ETF is publicly traded company for more then 20 years since IPO on 23 Jun 2005.

Invesco Dynamic Biotechnology & Genome ETF

Exchange:

AMEX

Full time employees:

Industry:

Asset Management

Sector:

Financial Services

The fund generally will invest at least 90% of its total assets in the securities that comprise the underlying intellidex. The underlying intellidex was composed of common stocks of U.S. biotechnology and genome companies. These companies are engaged principally in the research, development, manufacture and marketing and distribution of various biotechnological products, services and processes, etc. It is non-diversified.

Wheaton,

CIK: 0001209466
ISIN: US46137V7872
CUSIP: 46137V787